<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37567939</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19.</ArticleTitle><Pagination><StartPage>13095</StartPage><MedlinePgn>13095</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13095</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-40011-0</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) remains an epidemic worldwide. Most patients suffer residual symptoms, the so-called "Long COVID," which includes respiratory and neuropsychiatric symptoms. Brain Fog, one of the symptoms of Long COVID, is a major public health issue because it can impair patients' quality of life even after recovery from the disease. However, neither the pathogenesis nor the treatment of this condition remains unknown. We focused on serum ferritin levels in this study and collected information on the onset of Brain Fog through questionnaires and found that high ferritin levels during hospitalization were associated with the occurrence of Brain Fog. In addition, we excluded confounders as far as possible using propensity score analyses and found that ferritin was independently associated with Brain Fog in most of the models. We conducted phase analysis and evaluated the interaction of each phase with ferritin levels and Brain Fog. We found a positive correlation between serum ferritin levels during hospitalization and Brain Fog after COVID-19. High ferritin levels in patients with Brain Fog may reflect the contribution of chronic inflammation in the development of Brain Fog. This study provides a novel insight into the pathogenic mechanism of Brain Fog after COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishikura</LastName><ForeName>Teruyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan. t.ishikura@molneu.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. t.ishikura@molneu.med.osaka-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Tomohito</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitano</LastName><ForeName>Takaya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokuda</LastName><ForeName>Takechiyo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sumi-Akamaru</LastName><ForeName>Hisae</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naka</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Higashiosaka City Medical Center, 3-4-5 Nishiiwata, Higashiosaka, Osaka, 578-8588, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-73-2</RegistryNumber><NameOfSubstance UI="D005293">Ferritins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="N">Mental Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005293" MajorTopicYN="N">Ferritins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>12</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37567939</ArticleId><ArticleId IdType="pmc">PMC10421912</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-40011-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-40011-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lopez Bernal J, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 2021;385:585&#x2013;594. doi: 10.1056/NEJMoa2108891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study. J. Infect. 2021;83:237&#x2013;279. doi: 10.1016/j.jinf.2021.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.04.036</ArticleId><ArticleId IdType="pmc">PMC8110627</ArticleId><ArticleId IdType="pubmed">33984399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions.https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2022).</Citation></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:&#x223c;:text=Definition,months%20with%20no%20other%20explanation (2022).</Citation></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Almulla AF, Al-Hadrawi DS, Maes M. Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by neuroimmune and neuro-oxidative pathways which are caused by the inflammation during acute infection. J. Clin. Med. 2023;12:511. doi: 10.3390/jcm12020511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020511</ArticleId><ArticleId IdType="pmc">PMC9865328</ArticleId><ArticleId IdType="pubmed">36675440</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T, Trudler D, Oh CK, Lipton SA. Potential therapeutic use of the Rosemary diterpene carnosic acid for Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and Long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants (Basel) 2022;11:124. doi: 10.3390/antiox11010124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010124</ArticleId><ArticleId IdType="pmc">PMC8772720</ArticleId><ArticleId IdType="pubmed">35052628</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, et al. Long COVID syndrome-associated brain fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, et al. New-onset neuropsychiatric sequelae and &#x2018;long-COVID&#x2019; syndrome (Review) Exp. Ther. Med. 2022;24:705. doi: 10.3892/etm.2022.11641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11641</ArticleId><ArticleId IdType="pmc">PMC9622976</ArticleId><ArticleId IdType="pubmed">36324612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J. Long-COVID: Cognitive deficits (brain fog) and brain lesions in non&#x2013;hospitalized patients. Press. Med. 2022;51:104090. doi: 10.1016/j.lpm.2021.104090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lpm.2021.104090</ArticleId><ArticleId IdType="pmc">PMC8552626</ArticleId><ArticleId IdType="pubmed">34718113</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Stewart JM, Hatziagelaki E. Brain &#x2018;fog&#x2019;, inflammation a nd obesity: Key aspects of neuropsychiatric disorders improved by luteolin. Front. Neurosci. 2015;9:1&#x2013;11. doi: 10.3389/fnins.2015.00225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00225</ArticleId><ArticleId IdType="pmc">PMC4490655</ArticleId><ArticleId IdType="pubmed">26190965</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, et al. Epidemiology of post-COVID conditions beyond 1 year: A cross-sectional study. Public Health. 2023;216:39&#x2013;44. doi: 10.1016/j.puhe.2023.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2023.01.008</ArticleId><ArticleId IdType="pubmed">36791649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W, et al. Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses. Front. Neurol. 2022;13:877772. doi: 10.3389/fneur.2022.877772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType="pmc">PMC9174654</ArticleId><ArticleId IdType="pubmed">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss G. Iron metabolism in the anemia of chronic disease. Biochim. Biophys. Acta. 2009;1790:682&#x2013;693. doi: 10.1016/j.bbagen.2008.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2008.08.006</ArticleId><ArticleId IdType="pubmed">18786614</ArticleId></ArticleIdList></Reference><Reference><Citation>Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23:95&#x2013;104. doi: 10.1016/j.blre.2008.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2008.08.001</ArticleId><ArticleId IdType="pmc">PMC2717717</ArticleId><ArticleId IdType="pubmed">18835072</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazodier K, et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106:3483&#x2013;3489. doi: 10.1182/blood-2005-05-1980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-05-1980</ArticleId><ArticleId IdType="pmc">PMC1895045</ArticleId><ArticleId IdType="pubmed">16020503</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-H, et al. Serum cytokine profiles in patients with adult onset Still&#x2019;s disease. J. Rheumatol. 2003;30:2422&#x2013;2427.</Citation><ArticleIdList><ArticleId IdType="pubmed">14677188</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG. IL-1&#x3b2;/IL-6/CRP and IL-18/ferritin: Distinct inflammatory programs in infections. PLoS Pathog. 2016;12:1&#x2013;13. doi: 10.1371/journal.ppat.1005973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005973</ArticleId><ArticleId IdType="pmc">PMC5158075</ArticleId><ArticleId IdType="pubmed">27977798</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. BioFactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, et al. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J. Infect. 2020;81:647&#x2013;679. doi: 10.1016/j.jinf.2020.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.053</ArticleId><ArticleId IdType="pmc">PMC7313486</ArticleId><ArticleId IdType="pubmed">32592705</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelutti M, et al. Sex-dependent characteristics of neuro-long-COVID: Data from a dedicated neurology ambulatory service. J. Neurol. Sci. 2022;441:120355. doi: 10.1016/j.jns.2022.120355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120355</ArticleId><ArticleId IdType="pmc">PMC9328838</ArticleId><ArticleId IdType="pubmed">35994869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirois F. Steroid psychosis: A review. Gen. Hosp. Psychiatry. 2003;25:27&#x2013;33. doi: 10.1016/s0163-8343(02)00241-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0163-8343(02)00241-4</ArticleId><ArticleId IdType="pubmed">12583925</ArticleId></ArticleIdList></Reference><Reference><Citation>Loria A, Hershko C, Konijn AM. Serum ferritin in an elderly population. J. Gerontol. 1979;34:521&#x2013;524. doi: 10.1093/geronj/34.4.521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/34.4.521</ArticleId><ArticleId IdType="pubmed">448043</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh A, McMenamin J, Taylor B, Robertson C. SARS-CoV-2 delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397:2461&#x2013;2462. doi: 10.1016/S0140-6736(21)01358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01358-1</ArticleId><ArticleId IdType="pmc">PMC8201647</ArticleId><ArticleId IdType="pubmed">34139198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring AS, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. BMJ. 2022;376:e069761. doi: 10.1136/bmj-2021-069761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069761</ArticleId><ArticleId IdType="pmc">PMC8905308</ArticleId><ArticleId IdType="pubmed">35264324</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross AJ, Medow MS, Rowe PC, Stewart JM. What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin. Auton. Res. 2013;23:305&#x2013;311. doi: 10.1007/s10286-013-0212-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-013-0212-z</ArticleId><ArticleId IdType="pmc">PMC3896080</ArticleId><ArticleId IdType="pubmed">23999934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker MB, Brumfield SA, Lara Mejia PS. Neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A critical review of research methods. Front. Neurol. 2019;10:316. doi: 10.3389/fneur.2019.00316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00316</ArticleId><ArticleId IdType="pmc">PMC6454267</ArticleId><ArticleId IdType="pubmed">31001197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>